Showing results (1-10 of 377) with videos related to

Sort By:
Pageof 38
Breast Cancer Research : BCR|September 25, 2007
Breast cancer risk-assessment modelsD Gareth R Evans, Anthony Howell
Breast Cancer Research : BCR|March 2, 2013
Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relativesD Gareth R Evans, Anthony Howell, Sarah L Ingham, et al.
Nature Clinical Practice. Oncology|December 13, 2005
Mechanisms of Disease: prediction and prevention of breast cancer--cellular and molecular interactionsAnthony Howell, Andrew H Sims, Kai Ren Ong, et al.
Breast Cancer Research and Treatment|June 21, 2013
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancerD Gareth R Evans, Sarah L Ingham, Andrew Baildam, et al.
Familial Cancer|November 27, 2013
Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programmeD Gareth R Evans, Sarah Ingham, Sarah Dawe, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 5, 2009
Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]D Gareth R Evans
Orphanet Journal of Rare Diseases|June 24, 2009
Neurofibromatosis type 2 (NF2): a clinical and molecular reviewD Gareth R Evans
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2009
Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependentD Gareth R Evans, Fiona Lalloo, Linda Ashcroft, et al.
Breast Cancer Research and Treatment|November 20, 2013
Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referralSarah L Ingham, Matthew Sperrin, Andrew Baildam, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2013
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriersD Gareth R Evans, Sarah L Ingham, Iain Buchan, et al.
Pageof 38